Asia Pacific IVD Devices Contract Manufacturing Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The Asia Pacific IVD Devices Contract Manufacturing Market size is expected to reach US$ 19,247.0 Million by 2034 from US$ 6,535.7 Million in 2025. The market is estimated to record a CAGR of 12.8% from 2026 to 2034.

Executive Summary and Asia Pacific IVD Devices Contract Manufacturing Market Analysis:

The Asia Pacific IVD devices contract manufacturing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market is rapidly evolving, driven by cost-effective production, abundant skilled labor, and expanding healthcare infrastructure. China and India lead, with low raw material costs and government initiatives boosting outsourcing. Over 100% GDP growth is projected in these countries by 2040, increasing IVD device usage through public-private partnerships. Trends focus on point-of-care testing, with 60% of diagnostic firms outsourcing to reduce costs by 25% and launch times by 35%. For instance, expansions in India, Malaysia, and Singapore offer cost advantages, attracting CMOs for scalable production of immunoassays and molecular tests. Statistics indicate rising chronic diseases, with Asia Pacific holding 41.37% of the global share in 2024. In China, favorable policies support home healthcare, while India's aging population and chronic disease prevalence drive demand. Contract manufacturers provide end-to-end services, from assay development to packaging, ensuring compliance with global standards. Post-COVID, the government supports scaled IVD kit production, enhancing capabilities for infectious disease testing. Partnerships, such as those with Jabil and Flex, strengthen the ecosystem. The regional growth in outsourcing is fueled by technical advancements and patient pools. This enables OEMs to focus on innovation, addressing needs for affordable diagnostics in preventive care and rapid testing, ultimately improving healthcare access in populous markets.

Asia Pacific IVD Devices Contract Manufacturing Market: Strategic Insights

Asia Pacific IVD Devices Contract Manufacturing Market Segmentation Analysis:

• By Service Type, the Asia Pacific IVD Devices Contract Manufacturing Market is segmented into Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services. The Full-device Manufacturing segment dominated the market in 2025.
• By Device Type, the Asia Pacific IVD Devices Contract Manufacturing Market is segmented into IVD Consumables and IVD Equipment. The IVD Consumables segment dominated the market in 2025.

Asia Pacific IVD Devices Contract Manufacturing Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific IVD Devices Contract Manufacturing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Asia Pacific IVD Devices Contract Manufacturing Market Outlook

The significant opportunity for the IVD devices contract manufacturing market lies in the expansion into emerging economies, where rising healthcare infrastructure and government support are fostering demand for localized production. For instance, in India, the Production Linked Incentive (PLI) scheme for medical devices, launched with a budgetary outlay of US$37.92 million (₹3,420 crore), incentivizes domestic manufacturing of IVD products such as imaging devices and implants by offering financial rewards for incremental sales over five years from FY2022-2023 to FY2026-2027. This initiative has already led to 19 green-field projects being commissioned, enabling the production of high-end IVD tools such as MRI machines and CT scans that were previously imported. Statistics from global health data indicate that in lower-middle-income countries, governments spend an average of US$60 per person on health, while upper-middle-income countries allocate nearly US$270, with overall per capita health spending growing over 60% from 2000 to 2022, outpacing GDP growth. In low-income countries, combined government and donor spending averaged US$17 per capita in 2024, highlighting the potential for contract manufacturers to fill gaps in affordable diagnostics. This opportunity allows manufacturers to reduce costs through local supply chains and comply with regional regulations, enhancing accessibility in underserved areas. By partnering with local entities, contract manufacturers can leverage these initiatives to scale operations and meet the growing need for rapid diagnostic solutions in infectious diseases and chronic conditions.

Asia Pacific IVD Devices Contract Manufacturing Market Country Insights

By country, the Asia Pacific IVD Devices Contract Manufacturing Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. China held the largest share in 2025.

China's IVD devices contract manufacturing sector thrives under the National Medical Products Administration (NMPA) regulations, emphasizing quality assurance through GMP compliance and ISO 13485 standards. This framework supports rapid innovation and export capabilities, attracting global partnerships for scalable production of diagnostics. Key examples include STA Pharmaceutical, offering end-to-end CDMO services for IVD reagents and assays, leveraging expertise in API synthesis and formulation. ChemPartner provides custom assay development and manufacturing for immunoassays and molecular diagnostics, with facilities compliant with international standards. Hubei Biocause Pharmaceutical specializes in bulk reagent production for clinical chemistry tests, while Zhejiang Huahai Pharmaceutical focuses on companion diagnostics and PCR kits. Aurisco Pharmaceutical offers contract services for ELISA kits and point-of-care devices.

Statistics indicate that the number of FDA-approved API CMO facilities doubled from 2010-2019, representing 13% of global FDA-approved pharmaceutical sites. Primary-level institutions handle 52% of medical visits, driving demand for accessible diagnostics. Over 138 local manufacturers contribute to a vibrant CLIA sector with 8,000 instruments supplied. Moreover, trends include a shift toward molecular diagnostics and AI-integrated tools, with increasing outsourcing to mitigate development risks and enhance efficiency. Emphasis on infectious disease and NCD testing aligns with healthcare expansions, fostering collaborations such as those with global OEMs for cost-effective production.

Asia Pacific IVD Devices Contract Manufacturing Market Company Profiles

Some of the key players operating in the market include TE Connectivity Ltd, Jabil Inc, Nova Biomedical Corporation, Flex Ltd, Celestica Inc, Fujirebio Europe NV, Thermo Fisher Scientific Inc., Nemera, SMC Ltd, and HiArc

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific IVD Devices Contract Manufacturing Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise